SomnoMed Limited (SOMNF)
OTCMKTS · Delayed Price · Currency is USD
0.3852
-0.0162 (-4.04%)
At close: Mar 20, 2025

SomnoMed Company Description

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.

The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances.

In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

SomnoMed Limited
Country Australia
Founded 1987
Industry Medical Devices
Sector Healthcare
Employees 300

Contact Details

Address:
20 Clarke Street
Crows Nest, 2065
Australia
Phone 61 2 9467 0400
Website somnomed.com

Stock Details

Ticker Symbol SOMNF
Exchange OTCMKTS
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU000000SOM1
SIC Code 3843

Key Executives

Name Position
Karen Borg B.A. Co-Chief Executive Officer and Executive Director
Amrita Blickstead BME, M.B.A. Co-Chief Executive Officer and Executive Director
Mark Harding Senior Vice President of Global Marketing
Matthew Conlon Executive Vice President of Sales and Marketing - North America
Marco Van Kleef Vice President of Marketing and Sales - Europe
Ye-Fei Guo Chief Financial Officer
Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN Company Secretary
Christopher Bedford Vice President of Global Production and Product Development